{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T14:21:50Z","timestamp":1769437310804,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"INOVUERJ"},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["FAPERJ, E- 26\/204.043\/2024; E-26\/201.046\/2022; E-26\/200.883\/2021, E-26\/210.012\/2020"],"award-info":[{"award-number":["FAPERJ, E- 26\/204.043\/2024; E-26\/201.046\/2022; E-26\/200.883\/2021, E-26\/210.012\/2020"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["FAPERJ, E- 26\/204.043\/2024; E-26\/201.046\/2022; E-26\/200.883\/2021, E-26\/210.012\/2020"],"award-info":[{"award-number":["FAPERJ, E- 26\/204.043\/2024; E-26\/201.046\/2022; E-26\/200.883\/2021, E-26\/210.012\/2020"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302342\/2022-2; 307145\/2021-2"],"award-info":[{"award-number":["302342\/2022-2; 307145\/2021-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302342\/2022-2; 307145\/2021-2"],"award-info":[{"award-number":["302342\/2022-2; 307145\/2021-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-025-00810-1","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T01:25:30Z","timestamp":1739582730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early-onset Parkinson's disease in a patient with a rare homozygous pathogenic GBA1 variant and no Gaucher disease symptoms"],"prefix":"10.1007","volume":"26","author":[{"given":"Juliana Cordovil","family":"Cotrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Mina","family":"Piergiorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andressa Pereira","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Lehmkuhl","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula de Campos","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Tereza Ribeiro","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00edntia Barros","family":"Santos-Rebou\u00e7as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"810_CR1","doi-asserted-by":"publisher","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373(9680):2055-66. https:\/\/doi.org\/10.1016\/S0140-6736(09)60492-X. Erratum in: Lancet. 2009 Aug 29;374(9691):684","DOI":"10.1016\/S0140-6736(09)60492-X"},{"key":"810_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.parkreldis.2019.01.030","volume":"63","author":"C Velez-Pardo","year":"2019","unstructured":"Velez-Pardo C, Lorenzo-Betancor O, Jimenez-Del-Rio M, Moreno S, Lopera F, Cornejo-Olivas M et al (2019) The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru. Parkinsonism Relat Disord 63:204\u2013208. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.01.030","journal-title":"Parkinsonism Relat Disord"},{"key":"810_CR3","doi-asserted-by":"publisher","unstructured":"Salles P, Tirapegui JM, Chan\u00e1-Cuevas P (2024) Genetics of Parkinson's disease: Dominant forms and GBA. Neurology Perspectives 2267\u20130496.\u00a0https:\/\/doi.org\/10.1016\/j.neurop.2024.100153.","DOI":"10.1016\/j.neurop.2024.100153"},{"key":"810_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.694764","author":"E Menozzi","year":"2021","unstructured":"Menozzi E, Schapira AHV (2021) Exploring the Genotype-Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.694764","journal-title":"Front Neurol"},{"key":"810_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30006","author":"SRL Vieira","year":"2024","unstructured":"Vieira SRL, Mezabrovschi R, Toffoli M, Del Pozo SL, Menozzi E, Mullin S et al (2024) Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson\u2019s Disease. Mov Disord. https:\/\/doi.org\/10.1002\/mds.30006","journal-title":"Mov Disord"},{"issue":"9","key":"810_CR6","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s12035-020-01981-8","volume":"57","author":"EQ Vianna","year":"2020","unstructured":"Vianna EQ, Piergiorge RM, Gon\u00e7alves AP, Dos Santos JM, Calassara V, Rosenberg C et al (2020) Understanding the Landscape of X-linked Variants Causing Intellectual Disability in Females Through Extreme X Chromosome Inactivation Skewing. Mol Neurobiol 57(9):3671\u20133684. https:\/\/doi.org\/10.1007\/s12035-020-01981-8","journal-title":"Mol Neurobiol"},{"issue":"5","key":"810_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med."},{"issue":"1","key":"810_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A et al (2016) The Ensembl Variant Effect Predictor. Genome Biol 17(1):122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4","journal-title":"Genome Biol"},{"issue":"5","key":"810_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archneurol.2009.72","volume":"66","author":"J Mitsui","year":"2009","unstructured":"Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J et al (2009) Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66(5):571\u2013576. https:\/\/doi.org\/10.1001\/archneurol.2009.72","journal-title":"Arch Neurol"},{"issue":"W1","key":"810_CR10","doi-asserted-by":"publisher","first-page":"W420","DOI":"10.1093\/nar\/gkac373","volume":"50","author":"Y Xie","year":"2022","unstructured":"Xie Y, Li H, Luo X, Li H, Gao Q, Zhang L et al (2022) IBS 2.0: an upgraded illustrator for the visualization of biological sequences. Nucleic Acids Res 50(W1):W420\u2013W426. https:\/\/doi.org\/10.1093\/nar\/gkac373","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"810_CR11","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","volume":"14","author":"I Ron","year":"2005","unstructured":"Ron I, Horowitz M (2005) ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum Mol Genet 14(16):2387\u20132398. https:\/\/doi.org\/10.1093\/hmg\/ddi240","journal-title":"Hum Mol Genet"},{"key":"810_CR12","unstructured":"Leiden Open Variation Database (LOVD) (2024). GBA variant database. https:\/\/databases.lovd.nl\/shared\/variants\/GBA. Accessed 15 July 2024."},{"issue":"3","key":"810_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bcmd.2006.09.004","volume":"37","author":"R Rozenberg","year":"2006","unstructured":"Rozenberg R, Fox DC, Sobreira E, Pereira LV (2006) Detection of 12 new mutations in Gaucher disease Brazilian patients. Blood Cells Mol Dis 37(3):204\u2013209. https:\/\/doi.org\/10.1016\/j.bcmd.2006.09.004","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"810_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/mds.24945","volume":"27","author":"A McNeill","year":"2012","unstructured":"McNeill A, Duran R, Proukakis C, Bras J, Hughes D, Mehta A et al (2012) Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord 27(4):526\u2013532. https:\/\/doi.org\/10.1002\/mds.24945","journal-title":"Mov Disord"},{"issue":"4","key":"810_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/cells8040364","volume":"8","author":"GM Riboldi","year":"2019","unstructured":"Riboldi GM, Di Fonzo AB (2019) GBA, Gaucher Disease, and Parkinson\u2019s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells 8(4):364. https:\/\/doi.org\/10.3390\/cells8040364","journal-title":"Cells"},{"issue":"3","key":"810_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneurol.2007.68","volume":"65","author":"IF Mata","year":"2008","unstructured":"Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis BC et al (2008) Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 65(3):379\u2013382. https:\/\/doi.org\/10.1001\/archneurol.2007.68","journal-title":"Arch Neurol"},{"issue":"8","key":"810_CR17","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00415-018-8908-6","volume":"265","author":"LM Collins","year":"2018","unstructured":"Collins LM, Williams-Gray CH, Morris E, Deegan P, Cox TM, Barker RA (2018) The motor and cognitive features of Parkinson\u2019s disease in patients with concurrent Gaucher disease over 2 years: a case series. J Neurol 265(8):1789\u20131794. https:\/\/doi.org\/10.1007\/s00415-018-8908-6","journal-title":"J Neurol"},{"issue":"10","key":"810_CR18","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","volume":"65","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65(10):1353\u20131357. https:\/\/doi.org\/10.1001\/archneur.65.10.1353","journal-title":"Arch Neurol"},{"issue":"6","key":"810_CR19","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/302925","volume":"66","author":"V Koprivica","year":"2000","unstructured":"Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ et al (2000) Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet 66(6):1777\u20131786. https:\/\/doi.org\/10.1086\/302925","journal-title":"Am J Hum Genet"},{"issue":"2","key":"810_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1086\/423146","volume":"75","author":"M Slatkin","year":"2004","unstructured":"Slatkin M (2004) A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases. Am J Hum Genet 75(2):282\u2013293. https:\/\/doi.org\/10.1086\/423146","journal-title":"Am J Hum Genet"},{"issue":"9985","key":"810_CR21","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(15)60206-9","volume":"385","author":"DA Hughes","year":"2015","unstructured":"Hughes DA, Pastores GM (2015) Eliglustat for Gaucher\u2019s disease: trippingly on the tongue. Lancet 385(9985):2328\u20132330. https:\/\/doi.org\/10.1016\/S0140-6736(15)60206-9","journal-title":"Lancet"},{"key":"810_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-genom-083117-021256","volume":"19","author":"A Krause","year":"2018","unstructured":"Krause A, Seymour H, Ramsay M (2018) Common and Founder Mutations for Monogenic Traits in Sub-Saharan African Populations. Annu Rev Genomics Hum Genet 19:149\u2013175. https:\/\/doi.org\/10.1146\/annurev-genom-083117-021256","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"810_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/1096-8628(2001)9999:9999<::aid-ajmg1144>3.0.co;2-1","volume":"99","author":"JK Park","year":"2001","unstructured":"Park JK, Koprivica V, Andrews DQ, Madike V, Tayebi N, Stone DL et al (2001) Glucocerebrosidase mutations among African-American patients with type 1 Gaucher disease. Am J Med Genet 99(2):147\u2013151. https:\/\/doi.org\/10.1002\/1096-8628(2001)9999:9999%3c::aid-ajmg1144%3e3.0.co;2-1","journal-title":"Am J Med Genet"},{"issue":"1","key":"810_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bcmd.2009.02.008","volume":"43","author":"S Arndt","year":"2009","unstructured":"Arndt S, Heitner R, Lane A, Ramsay M (2009) Glucocerebrosidase gene mutations in black South Africans with Gaucher disease. Blood Cells Mol Dis 43(1):129\u2013133. https:\/\/doi.org\/10.1016\/j.bcmd.2009.02.008","journal-title":"Blood Cells Mol Dis"},{"key":"810_CR25","doi-asserted-by":"publisher","first-page":"156.e11","DOI":"10.1016\/j.neurobiolaging.2019.12.011","volume":"88","author":"AC Mahungu","year":"2020","unstructured":"Mahungu AC, Anderson DG, Rossouw AC, van Coller R, Carr JA, Ross OA et al (2020) Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson\u2019s disease. Neurobiol Aging 88:156.e11-156.e14. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.12.011","journal-title":"Neurobiol Aging"},{"issue":"17","key":"810_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361(17):1651\u20131661. https:\/\/doi.org\/10.1056\/NEJMoa0901281","journal-title":"N Engl J Med"},{"issue":"1","key":"810_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/hmg\/ddq454","volume":"20","author":"S Lesage","year":"2011","unstructured":"Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C et al (2011) Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease. Hum Mol Genet 20(1):202\u2013210. https:\/\/doi.org\/10.1093\/hmg\/ddq454","journal-title":"Hum Mol Genet"},{"issue":"6","key":"810_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","volume":"78","author":"M Anheim","year":"2012","unstructured":"Anheim M, Elbaz A, Lesage S, Durr A, Condroyer C, Viallet F et al (2012) Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 78(6):417\u2013420. https:\/\/doi.org\/10.1212\/WNL.0b013e318245f476","journal-title":"Neurology"},{"issue":"9","key":"810_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00702-022-02531-3","volume":"129","author":"SRL Vieira","year":"2022","unstructured":"Vieira SRL, Schapira AHV (2022) Glucocerebrosidase mutations and Parkinson disease. J Neural Transm (Vienna) 129(9):1105\u20131117. https:\/\/doi.org\/10.1007\/s00702-022-02531-3","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"810_CR30","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1212\/NXG.0000000000000523","volume":"6","author":"L Straniero","year":"2020","unstructured":"Straniero L, Asselta R, Bonvegna S, Rimoldi V, Melistaccio G, Sold\u00e0 G et al (2020) The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD. Neurol Genet 6(6):e523. https:\/\/doi.org\/10.1212\/NXG.0000000000000523","journal-title":"Neurol Genet"},{"issue":"6","key":"810_CR31","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/mds.28987","volume":"37","author":"L Straniero","year":"2022","unstructured":"Straniero L, Rimoldi V, Monfrini E, Bonvegna S, Melistaccio G, Lake J et al (2022) Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson\u2019s Disease Risk. Mov Disord 37(6):1202\u20131210. https:\/\/doi.org\/10.1002\/mds.28987","journal-title":"Mov Disord"},{"issue":"5","key":"810_CR32","doi-asserted-by":"publisher","first-page":"e05846","DOI":"10.1002\/ccr3.5846","volume":"10","author":"H Jilani","year":"2022","unstructured":"Jilani H, Hsoumi F, Rejeb I, Elaribi Y, Hizem S, Sebai M et al (2022) A rare homozygous p.Arg87Trp variant of the GBA gene in Gaucher disease: A case report. Clin Case Rep 10(5):e05846. https:\/\/doi.org\/10.1002\/ccr3.5846","journal-title":"Clin Case Rep"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00810-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-025-00810-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00810-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:03:50Z","timestamp":1769400230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-025-00810-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1007\/s10048-025-00810-1","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}